We also expand the molecular spectrum of ADAT3-related neurodevelopmental disorders by reporting 21 patients presenting with IDs, structural brain anomalies and global growth retardation carrying the previously identified homozygous p.Val144Met variant or the biallelic p.Ala196Val/p.Ala196Leu variants. This evidence concerns the gene ADAT3 and neurodevelopmental disorder.